Skip to main content
. 2021 Aug 3;16(8):e0255642. doi: 10.1371/journal.pone.0255642

Table 1. Baseline characteristics by degree of polypharmacy.

Characteristic+ No polypharmacy (n = 738,923,785) Minor polypharmacy (n = 341,779,401) Moderate polypharmacy (n = 256,247,011) Major polypharmacy (n = 779,309,084)
Age (years), median (IQR) 74 (69–80) 73 (68–79) 73 (68–80) 75 (70–81)
Female sex, % 55.5 57.5 56.1 57.5
Race, %
 White 66.2 62.5 66.0 67.2
 Black/African American 5.7 6.0 7.2 6.4
 Other 4.3 4.7 4.0 2.9
 More than one race 0.1 0.1 0.2 0.2
Hispanic or Latino ethnicity, % 7.1 7.7 7.9 6.1
Chronic conditions, median (IQR) 0 (1–2) 2 (1–3) 2 (1–3) 3 (2–4)

+ All comparisons between no polypharmacy vs. minor polypharmacy vs. moderate polypharmacy vs. major polypharmacy groups were deemed statistically significant if p<0.0001